(S1 (S (S (NP (NN p21)) (VP (VBZ delays) (NP (NN tumor) (NN onset)) (PP (IN by) (NP (NP (NN preservation)) (PP (IN of) (NP (JJ chromosomal) (NN stability))))))) (. .)))
(S1 (S (S (NP (DT The) (NN p53) (NN protein)) (VP (VBZ suppresses) (NP (NN tumorigenesis)) (PP (IN by) (S (VP (VBG initiating) (NP (NP (JJ cellular) (NNS functions)) (PP (JJ such) (IN as) (NP (NP (NP (NN cell) (NN cycle) (NN arrest)) (CC and) (NP (NN apoptosis))) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (NN DNA) (NN damage))))))))))))) (. .)))
(S1 (S (S (NP (NP (NP (DT A) (NN p53) (NN mutant)) (, ,) (NP (NN p53R172P))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VP (VBZ is) (ADJP (JJ deficient) (PP (IN for) (NP (NN apoptosis))))) (CC but) (VP (VBZ retains) (NP (NP (DT a) (JJ partial) (NN cell) (NN cycle) (NN arrest)) (NN function)))))) (, ,)) (VP (VBZ delays) (NP (NP (NN tumor) (NN onset)) (PP (IN in) (NP (NNS mice)))))) (. .)))
(S1 (S (S (ADVP (RB Remarkably)) (, ,) (NP (NP (NNS lymphomas)) (VP (VBG arising) (PP (IN in) (NP (NP (JJ Trp53-LRB-515C/515C-RRB-) (NNS mice)) (PRN (-LRB- -LRB-) (NP (NN encoding) (NN p53R172P)) (-RRB- -RRB-)))))) (VP (VBP retain) (NP (JJ stable) (NNS genomes)))) (. .)))
(S1 (S (S (PP (IN Given) (NP (NP (DT the) (JJ dominant) (NN role)) (PP (IN of) (NP (NN p21))) (PP (IN in) (NP (NN p53) (NN cell) (NN cycle) (NN control))))) (, ,) (NP (PRP we)) (VP (VBD crossed) (NP (NN Trp53-LRB-515C/515C-RRB-) (NNS mice)) (PP (IN onto) (NP (DT a) (JJ p21-null) (NN background))) (S (VP (TO to) (VP (VB determine) (SBAR (IN whether) (S (NP (NN p21)) (VP (VBD was) (VP (VBN required) (PP (IN for) (S (VP (VBG maintaining) (NP (NP (JJ chromosomal) (NN stability)) (CC and) (NP (JJ delaying) (NN tumor) (NN onset))))))))))))))) (. .)))
(S1 (S (S (NP (NP (NN Loss)) (PP (IN of) (NP (NN p21)))) (ADVP (RB completely)) (VP (VBD abolished) (NP (NP (DT the) (NP (NN cell) (NN cycle) (NN arrest)) (NN function)) (PP (IN of) (NP (NP (NN p53R172P)) (CC and) (NP (VBN accelerated) (NN tumor) (NN onset)))) (PP (IN in) (NP (JJ Trp53-LRB-515C/515C-RRB-) (NNS mice)))))) (. .)))
(S1 (S (S (NP (NP (JJ Cytogenetic) (NN examination)) (PP (IN of) (NP (NP (NN Trp53-LRB-515C/515C-RRB-) (NN p21-LRB--/--RRB-) (NNS sarcomas)) (CC and) (NP (NNS lymphomas))))) (VP (VBD revealed) (NP (NP (NP (NN aneuploidy)) (CC and) (NP (JJ chromosomal) (NNS aberrations))) (SBAR (WHNP (WDT that)) (S (VP (VBD were) (ADJP (JJ absent) (PP (IN in) (NP (JJ Trp53-LRB-515C/515C-RRB-) (NNS malignancies)))))))))) (. .)))
(S1 (S (ADVP (RB Thus)) (, ,) (NP (NN p21)) (VP (VP (VBN coupled) (NP (NP (JJ p53-dependent) (NN checkpoint) (NN control)) (CC and) (NP (NP (NN preservation)) (PP (IN of) (NP (JJ chromosomal) (NN stability)))))) (, ,) (CC and) (VP (VBD cooperated) (PP (IN with) (NP (NN apoptosis))) (PP (IN in) (S (VP (VBG suppressing) (NP (NP (NN tumor) (NN onset)) (PP (IN in) (NP (NNS mice))))))))) (. .)))
